StockData
Charles River Laboratories International, Inc. logo

Charles River Laboratories International, Inc. (CRL) income statement

CRLNYSEServices-Commercial Physical & Biological ResearchFiscal year ends December 27
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 27, 2026Last filing: 10-Q on Nov 4, 2026Score 6/30215% above fair value
$333.25+1.09 (+0.33%)

Close on Nov 18, 2026Market cap $15.91BP/E –Yield –

Charles River Laboratories International, Inc. income statement

Ratios

Latest available, balances at Jun 27, 2026

Profitability, TTM

Gross margin
–
Operating margin
2.3%
Net margin
-6.0%
Return on equity, FY2025
-4.4%

Financial strength

Current ratio
1.35
Debt to equity
0.92
Debt to assets
34.9%
Cash to current liabilities
16.9%

Valuation

P/E ratio
–
Price to sales
3.98
Price to book
5.60
Dividend yield
–

See a number that looks wrong?